Mignonette Du Plessis to Young Adult
This is a "connection" page, showing publications Mignonette Du Plessis has written about Young Adult.
Connection Strength
0,847
-
Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
Score: 0,147
-
Molecular Characterization of Corynebacterium diphtheriae Outbreak Isolates, South Africa, March-June 2015. Emerg Infect Dis. 2017 08; 23(8):1308-1315.
Score: 0,087
-
Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa. BMC Microbiol. 2017 Feb 21; 17(1):40.
Score: 0,084
-
Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013. J Clin Microbiol. 2016 05; 54(5):1326-34.
Score: 0,079
-
Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014 May; 68(5):455-61.
Score: 0,068
-
Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019-2020. J Infect Dis. 2025 Apr 15; 231(4):e697-e707.
Score: 0,037
-
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project. J Infect. 2025 Mar; 90(3):106426.
Score: 0,037
-
Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
Score: 0,036
-
Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
Score: 0,036
-
Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
Score: 0,035
-
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
Score: 0,030
-
Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
Score: 0,025
-
The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015. J Infect Dis. 2019 05 05; 219(11):1697-1704.
Score: 0,025
-
Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
Score: 0,023
-
Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014. J Med Virol. 2017 10; 89(10):1759-1767.
Score: 0,022
-
Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One. 2014; 9(9):e107666.
Score: 0,018
-
High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
Score: 0,018
-
Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688. J Clin Microbiol. 2012 Nov; 50(11):3678-86.
Score: 0,016
-
High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol. 2010 Jun; 48(6):2016-21.
Score: 0,013
-
An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010 Jan; 48(1):184-91.
Score: 0,013